文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

危重症肝硬化患者的医院获得性血流感染:EUROBACT-2国际队列研究的事后分析

Hospital-acquired bloodstream infections in critically ill cirrhotic patients: a post-hoc analysis of the EUROBACT-2 international cohort study.
PubMed 文献 · Ann Intensive Care · 2024-05-02
一句话结论在ICU医院获得性血流感染患者中,肝硬化患者腹腔来源和革兰阳性感染更多,尤其以屎肠球菌血流感染风险更高(OR 2.5,95%CI 1.3-4.5)及死亡率更高(HR 1.3,95%CI 1.01-1.7)。

本研究为EUROBACT-2前瞻性国际队列研究的事后分析,纳入1059例来自101个中心的医院获得性血流感染ICU患者,其中160例有肝硬化。结果显示,肝硬化患者的感染来源以腹腔为主(35.6%),而非肝硬化患者以肺部为主(18.9%)(p < 0.01)。肝硬化患者革兰阳性血流感染比例为42.3%,高于非肝硬化患者的33.2%(p = 0.02)。肝硬化患者屎肠球菌血流感染发生率更高(11.5% vs 4.5%,p < 0.01),校正混杂因素后,肝硬化与屎肠球菌血流感染风险升高相关(OR 2.5,95%CI 1.3-4.5,p < 0.01)。肝硬化患者死亡率高于非肝硬化患者(HR 1.3,95%CI 1.01-1.7,p = 0.045)。结论:危重症肝硬化合并医院获得性血流感染的患者具有独特的流行病学特征,革兰阳性感染更多,尤其是屎肠球菌。

要点

  • 在ICU医院获得性血流感染患者中,肝硬化患者感染来源以腹腔为主(35.6%),非肝硬化患者以肺部为主(18.9%)(p < 0.01)。
  • 肝硬化患者革兰阳性血流感染占42.3%,高于非肝硬化患者的33.2%(p = 0.02)。
  • 肝硬化患者屎肠球菌血流感染发生率为11.5%,高于非肝硬化患者的4.5%(p < 0.01);校正混杂因素后,肝硬化与屎肠球菌血流感染风险升高相关(OR 2.5,95%CI 1.3-4.5,p < 0.01)。
  • 肝硬化患者医院获得性血流感染最常见的病原体为克雷伯菌属(16.5%)、凝固酶阴性葡萄球菌(13.7%)和屎肠球菌(11.5%)。
  • 肝硬化患者死亡率高于非肝硬化患者(HR 1.3,95%CI 1.01-1.7,p = 0.045)。

适用人群与场景

  • ICU中发生医院获得性血流感染的成人患者,来自EUROBACT-2前瞻性国际队列研究,共1059例,其中160例有肝硬化。

研究设计与关键结果

  • 研究类型:EUROBACT-2前瞻性国际队列研究的事后分析,纳入101个中心的1059例医院获得性血流感染ICU患者,其中肝硬化患者160例。
  • 感染来源:肝硬化患者以腹腔为主(35.6%),非肝硬化患者以肺部为主(18.9%)(p < 0.01)。
  • 革兰阳性血流感染比例:肝硬化患者42.3%,非肝硬化患者33.2%(p = 0.02)。
  • 肝硬化患者医院获得性血流感染最常见病原体:克雷伯菌属(16.5%)、凝固酶阴性葡萄球菌(13.7%)、屎肠球菌(11.5%)。
  • 屎肠球菌血流感染:肝硬化患者11.5%,非肝硬化患者4.5%(p < 0.01);校正混杂因素后,肝硬化与屎肠球菌血流感染风险升高相关(OR 2.5,95%CI 1.3-4.5,p < 0.01)。
  • 死亡率:肝硬化患者高于非肝硬化患者(HR 1.3,95%CI 1.01-1.7,p = 0.045)。

证据类型、等级与局限

  • 证据类型:基于前瞻性国际队列研究(EUROBACT-2)的事后分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在ICU医院获得性血流感染的肝硬化患者中,感染来源以腹腔为主,经验性抗感染方案需覆盖革兰阳性菌,尤其是屎肠球菌。
  • 肝硬化患者屎肠球菌血流感染风险较非肝硬化患者升高(OR 2.5,95%CI 1.3-4.5),且死亡率更高(HR 1.3,95%CI 1.01-1.7),应加强病情评估与监测。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Hospital-acquired bloodstream infections are common in the intensive care unit (ICU) and have a high mortality rate. Patients with cirrhosis are especially susceptible to infections, yet there is a knowledge gap in the epidemiological distinctions in hospital-acquired bloodstream infections between cirrhotic and non-cirrhotic patients in the ICU. It has been suggested that cirrhotic patients, present a trend towards more gram-positive infections, and especially enterococcal infections. This study aims to describe epidemiological differences in hospital-acquired bloodstream infections between cirrhotic and non-cirrhotic patients hospitalized in the ICU regarding infection sources, microorganisms and mortality.

METHODS: Using prospective Eurobact-2 international cohort study data, we compared hospital-acquired bloodstream infections sources and microorganisms in cirrhotic and non-cirrhotic patients. The association between Enterococcus faecium and cirrhosis was studied using a multivariable mixed logistic regression. The association between cirrhosis and mortality was assessed by a multivariable frailty Cox model.

RESULTS: Among the 1059 hospital-acquired bloodstream infections patients included from 101 centers, 160 had cirrhosis. Hospital-acquired bloodstream infection source in cirrhotic patients was primarily abdominal (35.6%), while it was pulmonary (18.9%) for non-cirrhotic (p < 0.01). Gram-positive hospital-acquired bloodstream infections accounted for 42.3% in cirrhotic patients compared to 33.2% in non-cirrhotic patients (p = 0.02). Hospital-acquired bloodstream infections in cirrhotic patients were most frequently caused by Klebsiella spp (16.5%), coagulase-negative Staphylococci (13.7%) and E. faecium (11.5%). E. faecium bacteremia was more frequent in cirrhotic patients (11.5% versus 4.5%, p < 0.01). After adjusting for possible confounding factors, cirrhosis was associated with higher E. faecium hospital-acquired bloodstream infections risk (Odds ratio 2.5, 95% CI 1.3-4.5, p < 0.01). Cirrhotic patients had increased mortality compared to non-cirrhotic patients (Hazard Ratio 1.3, 95% CI 1.01-1.7, p = 0.045).

CONCLUSIONS: Critically ill cirrhotic patients with hospital-acquired bloodstream infections exhibit distinct epidemiology, with more Gram-positive infections and particularly Enterococcus faecium.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Wozniak H, Tabah A, Barbier F, et al. Hospital-acquired bloodstream infections in critically ill cirrhotic patients: a post-hoc analysis of the EUROBACT-2 international cohort study. Ann Intensive Care. 2024. PMID: 38698291. doi:10.1186/s13613-024-01299-x

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。